Elevance Health, Inc. (ELV) stock
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$400.84−33.09 (-7.63%)
Close on Nov 18, 2026Market cap $86.60BP/E 17.1Yield –
Elevance Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Elevance Health's revenue for the twelve months ending Sep 30, 2026 was $201.83B, up 3.6% year over year. For fiscal 2025 it was $199.13B, up 12.5% from the year before. Over ten years it grew 9.7% a year on average. The highest annual figure on record is $199.13B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $199.13B | +12.5% |
| FY2024 | Dec 31, 2024 | $177.01B | +3.3% |
| FY2023 | Dec 31, 2023 | $171.34B | +9.4% |
| FY2022 | Dec 31, 2022 | $156.60B | +13.0% |
| FY2021 | Dec 31, 2021 | $138.64B | +13.8% |
| FY2020 | Dec 31, 2020 | $121.87B | +16.9% |
| FY2019 | Dec 31, 2019 | $104.21B | +13.1% |
| FY2018 | Dec 31, 2018 | $92.11B | +2.3% |
| FY2017 | Dec 31, 2017 | $90.04B | +6.1% |
| FY2016 | Dec 31, 2016 | $84.86B | +7.2% |
| FY2015 | Dec 31, 2015 | $79.16B | +7.2% |
| FY2014 | Dec 31, 2014 | $73.87B | +4.0% |
| FY2013 | Dec 31, 2013 | $71.02B | +15.5% |
| FY2012 | Dec 31, 2012 | $61.50B | +1.3% |
| FY2011 | Dec 31, 2011 | $60.71B | +3.4% |
| FY2010 | Dec 31, 2010 | $58.70B | -9.6% |
| FY2009 | Dec 31, 2009 | $64.94B | +6.0% |
| FY2008 | Dec 31, 2008 | $61.25B | +0.1% |
| FY2007 | Dec 31, 2007 | $61.17B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $51.43B | +1.4% |
| Q2 FY2026 | Jun 30, 2026 | $50.47B | +1.4% |
| Q1 FY2026 | Mar 31, 2026 | $50.18B | +2.6% |
| Q4 FY2025 | Dec 31, 2025 | $49.75B | +9.5% |
| Q3 FY2025 | Sep 30, 2025 | $50.71B | +12.4% |
| Q2 FY2025 | Jun 30, 2025 | $49.78B | +13.4% |
| Q1 FY2025 | Mar 31, 2025 | $48.89B | +14.8% |
| Q4 FY2024 | Dec 31, 2024 | $45.44B | +6.6% |
| Q3 FY2024 | Sep 30, 2024 | $45.11B | +5.3% |
| Q2 FY2024 | Jun 30, 2024 | $43.89B | +0.5% |
| Q1 FY2024 | Mar 31, 2024 | $42.58B | +1.0% |
| Q4 FY2023 | Dec 31, 2023 | $42.65B | +6.8% |
| Q3 FY2023 | Sep 30, 2023 | $42.85B | +7.3% |
| Q2 FY2023 | Jun 30, 2023 | $43.67B | +13.0% |
| Q1 FY2023 | Mar 31, 2023 | $42.17B | +10.7% |
| Q4 FY2022 | Dec 31, 2022 | $39.93B | +9.2% |
| Q3 FY2022 | Sep 30, 2022 | $39.94B | +11.5% |
| Q2 FY2022 | Jun 30, 2022 | $38.63B | +14.1% |
| Q1 FY2022 | Mar 31, 2022 | $38.10B | +17.6% |
| Q4 FY2021 | Dec 31, 2021 | $36.58B | +14.9% |
| Q3 FY2021 | Sep 30, 2021 | $35.82B | +15.0% |
| Q2 FY2021 | Jun 30, 2021 | $33.85B | +15.7% |
| Q1 FY2021 | Mar 31, 2021 | $32.39B | +9.3% |
| Q4 FY2020 | Dec 31, 2020 | $31.82B | +16.1% |
| Q3 FY2020 | Sep 30, 2020 | $31.16B | +16.8% |
| Q2 FY2020 | Jun 30, 2020 | $29.26B | +14.9% |
| Q1 FY2020 | Mar 31, 2020 | $29.62B | +20.1% |
| Q4 FY2019 | Dec 31, 2019 | $27.41B | +17.3% |
| Q3 FY2019 | Sep 30, 2019 | $26.67B | +14.7% |
| Q2 FY2019 | Jun 30, 2019 | $25.47B | +11.0% |
| Q1 FY2019 | Mar 31, 2019 | $24.67B | +9.4% |
| Q4 FY2018 | Dec 31, 2018 | $23.37B | +3.0% |
| Q3 FY2018 | Sep 30, 2018 | $23.25B | +3.7% |
| Q2 FY2018 | Jun 30, 2018 | $22.94B | +2.4% |
| Q1 FY2018 | Mar 31, 2018 | $22.54B | +0.1% |
| Q4 FY2017 | Dec 31, 2017 | $22.68B | +4.5% |
| Q3 FY2017 | Sep 30, 2017 | $22.43B | – |
| Q2 FY2017 | Jun 30, 2017 | $22.41B | – |
| Q1 FY2017 | Mar 31, 2017 | $22.53B | – |
| Q4 FY2016 | Dec 31, 2016 | $21.71B | – |
See a number that looks wrong?